🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to noninvasively measure the anti-inflammatory...
Status
Completed
Location
AAADRS
Start Date
2009-01
Trial ID
NCT00894231
Treatments Being Tested
this study is aiming at learning more about primary ciliary dyskinesia (PCD...
Status
Recruiting
Location
Arkansas Children's Hospital
Start Date
2021-06-14
Trial ID
NCT05287022
A Phase 2 open label, dose escalation study to find the minimally and maxim...
Status
Completed
Location
University of Alabama @ Birmingham
Start Date
2011-03
Trial ID
NCT01265888
Treatments Being Tested
Primary Ciliary Dyskinesia (PCD) is a rare genetic disorder characterized b...
Status
Unknown
Location
University Hospital Münster
Start Date
2021-01-01
Trial ID
NCT04949308
The purpose of this study is to evaluate the efficacy and safety of open-la...
Status
Completed
Location
Oregon Health and Science University
Start Date
2019-01-28
Trial ID
NCT03748992
Treatments Being Tested
Primary ciliary dyskinesia (PCD) is a rare genetic disorder characterized b...
Status
Completed
Location
Respiratory Department Lausanne University Hospital
Start Date
2014-02
Trial ID
NCT02133547
Background: Primary ciliary dyskinesia (PCD) is a rare genetic disease char...
Status
Unknown
Location
Pediatric Department, Ziv Medical Center
Start Date
2010-07
Trial ID
NCT00739817
A Study of the relation of COVID-19 infection and its severity to upper and...
Status
Unknown
Location
Tampere University Hospital
Start Date
2021-01-15
Trial ID
NCT04728919
Primary: The primary objective of this study is to evaluate the efficacy o...
Status
Completed
Location
Ishwar Institute & Hospital
Start Date
2021-11-01
Trial ID
NCT05599919
Treatments Being Tested
This is a prospective study. It enrolls subjects with allergic rhinitis, wi...
Status
Not Yet Recruiting
Location
Huiying Wang
Start Date
2025-08
Trial ID
NCT07114107